SarcomaBCB data dictionary

Patient (13 items)


Centre (NetSarc)
Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No
Description : Centre NetSarc Possible values :
Lyon CLB, Hôp. Civil Strasbourg, Hôp. Pontchaillou, CPS Strasbourg, Saint-Louis, St Etienne ICLN, Villejuif IGR, Bordeaux Pellegrin, CHRU De Dijon, CHU Nancy, Bergonié, Curie, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Montpellier ICM, Nantes ICO , IUCT Toulouse, Strasbourg CHU, CJP, Timone, Cochin, Rennes CEM, Limoges Dupuytren, Tours Trousseau, Rouen CHB, Nantes CHU, Reims IJG, Reims CHU, Besançon CHU, La Réunion CHU, Tenon, Pitié Salpétrière, Bicêtre

Initials
Type : Free value
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No
Description : Patient initials : 4 characters (2 of Lastname, 2 of Firstname)Attention to compound names

Birth date
Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No
Description : The patient's birth date

Sex
Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No
Description : The patient's gender Possible values :
Female, Male

Creation date patient
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description : The date when the patient has been created in the database

Patient information
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Consent information Possible values :
Uninformed, Addressed mail, No opposition, Opposition, Consent

Significant previous history
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No
Description : No: no significant previous historyNF1: presence of neurofibromatosis type 1 or Recklinghausen diseaseNF2: presence of neurofibromatosis type 2Radiation therapy: tumour developed in a previously radiated areaLymphoedema: tumour developed on a preexisting lymphoedemaGardner: presence of a Gardner syndromLi Fraumeni: presence of a Li Fraumeni diseasePrevious cancer: the patient has previously developed another cancer different from the current tumourOther: other significant previous history with a possible link with the current tumour Possible values :
No, Previous cancer, NF1, NF2, Gardner syndrome, Li Fraumeni syndrome, Retinoblastoma syndrome, Immunodepressed - HIV, Immunodepressed - other, Ollier disease, Maffucci syndrome, Paget disease, Multiple osteochondromas, McCune-Albright syndrome, Rothmund-Thomson syndrome, Werner syndrome, Cherubism, Other genetic disease, Other, Unknown, Familial GISTs, Stratiakis-Carney dyad, Carney Triad, Other malignancy in family

Significant previous history detail
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description :

Date of last contact
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description : Date of the last follow up evaluation or date of death

Vital status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Vital status at last contact Possible values :
Alive, Dead

Diagnosis during pregnancy
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Diagnosis during pregnancy (CALG network enrollment) Possible values :
Yes, No

Quality control NetSarc
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Quality control NetSarc performed Possible values :
Yes, No

Date of control
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description : Date of quality control

Primary tumour (31 items)


Type of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : point de départ du développement de la tumeur<br> Possible values :
Soft tissue, Viscera, Bone

Site of tumour
Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No
Description : Site of tumour according to the scroll menu Possible values :
- Soft tissue
- Head and neck
- Superficial areas of head
- Sinus and nasal fossa
- Deep facial areas
- Orbit
- Anterior skull base
- Ear - lateral skull base and nasoharynx
- Oral cavity - oropharynx
- Visceral space of the neck
- Neck NOS
- Trunk wall
- Chest wall
- Axilla
- Abdominal wall
- Trunk - paraspinal
- Buttock
- Groin
- Internal trunk
- Retroperitoneum
- Peritoneum
- Pelvis
- Thorax internal
- Large vessels
- Paratesticular
- Lower limb
- Thigh
- Knee
- Leg
- Ankle
- Foot
- Toe
- Upper limb
- Shoulder girdle
- Upper arm
- Elbow
- Forearm
- Wrist
- Hand
- Finger
- Viscera
- Gastro Intestinal tractus
- Oesophagus
- Stomach
- Duodenum
- Appendix
- Small intestine
- Colon
- Rectum
- Anus
- Gyneacological area
- Uterus
- Ovary
- Fallopian tube
- Vagina
- Vulva
- Others
- Breast
- Lung
- Heart
- Pleura
- Thymus
- Thyroid
- Kidney
- Bladder
- Ureter
- Prostate
- Testis
- Epididymis
- Penis
- Spleen
- Liver
- Pancreas
- Gallbladder
- Salivary gland
- Tonsil
- Adrenal
- Brain
- Meninges
- Lymph node
- Bone
- Skull and face bone
- Skull NOS
- Ethmoid
- Superior maxilla
- Mandible
- Bone face
- Upper airways
- Larynx
- Bronchus
- Nasal septum
- Spine
- Cervical spine
- Dorsal spine
- Lumbar spine
- Basin, sacrum, coccyx
- Basin
- Sacrum
- Coccyx
- Hip joint
- Other thoracic bone
- Rib
- Sternum
- Clavicle
- Superior limb and shoulder
- Bone shoulder girdle
- Scapula
- Shoulder joint
- Humerus
- Elbow joint
- Ulna
- Radius
- Wirst joint
- Hand bone NOS
- Carpal (Hand)
- Metacarpals (Hand)
- Hand phalanges
- Hand joint
- Inferior limb
- Femur
- Patella
- Knee joint
- Tibia
- Fibula
- Ankle joint
- Bone foot NOS
- Tarsals (Foot)
- Metatarsals (Foot)
- Foot phalanges
- Foot joint

Size of tumour (mm)
Type : Free value
Content : DECIMAL
Mandatory : No
Multiple values : No
Unique : No
Description : Largest diameter of the tumour expressed in mm

Depth of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis Possible values :
Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary

Histotype
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0) Possible values :
- Benign lesion
- Benign adipocytic tumours
- Angiolipoma
- Angiomyolipoma
- Chondroid lipoma
- Hibernoma
- Lipoblastoma/lipoblastomatosis
- Lipoma
- Lipomatosis
- Lipomatosis of nerve
- Myelolipoma
- Myolipoma
- Spindle cell / pleomorphic lipoma
- Benign chondrogenic tumours
- Chondroma
- Enchondroma
- Osteochondroma
- Osteochondromyxoma
- Periosteal chondroma
- Subungueal exostosis
- Synovial chondromatosis
- Benign fibroblastic/myofibroblastic tumours
- Adenofibroma
- Angiofibroma
- Angiomyofibroblastoma
- Calcifying aponeurotic fibroma
- Calcifying fibrous tumour
- Cellular angiofibroma
- Desmoplastic fibroblastoma
- Elastofibroma
- Fasciitis
- Fibro-osseous pseudotumour of digits
- Fibroma of tendon sheath
- Fibromatosis colli
- Fibrous hamartoma of infancy
- Gardner fibroma
- Inclusion body fibromatosis
- Intra-nodal palisaded myofibroblastoma
- Ischaemic fasciitis
- Juvenile hyaline fibromatosis
- Mammary-type myofibroblastoma
- Myositis ossificans
- Nasopharyngeal angiofibroma
- Nodular fasciitis
- Nuchal-type fibroma
- Organ-associated pseudosarcomatous myofibroblastic proliferations
- Other fibromas
- Proliferative fasciitis
- Proliferative myositis
- Benign fibro-histiocytic tumours
- Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws)
- Deep benign fibrous histiocytoma
- Fibrous histiocytoma
- Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma)
- Non Ossifying fibroma
- Tenosynovial giant cell tumour
- Tenosynovial giant cell tumour, diffuse type
- Tenosynovial giant cell tumour, localized type
- Benign nerve sheath tumours
- Benign Triton tumour
- Dermal nerve sheath myxoma
- Ectopic meningioma
- Granular cell tumour
- Hybrid nerve sheath tumours
- Melanotic schwannoma
- Nasal glial heterotopia
- Neurofibroma
- Neurothekeoma
- Perineurioma
- Plexiform neurofibroma
- Schwannoma
- Solitary circumscribed neuroma
- Benign notochordal tumour
- Benign osteogenic tumours
- Osteoid osteoma
- Osteoma
- Benign pericytic tumours
- Angioleiomyoma
- Glomus tumour
- Myofibroma / myofibromatosis
- Myopericytoma
- Benign skeletal muscle tumours
- Rhabdomyoma
- Rhabdomyoma - adult type
- Rhabdomyoma - fetal type
- Rhabdomyoma - genital type
- Benign smooth muscle tumours
- Atypical polypoid adenomyoma
- Bizarre nuclei leiomyoma
- Cellular leiomyoma
- Diffuse leiomyomatosis
- Dissecans leiomyoma
- Epithelioid leiomyoma
- Intraveinous leiomyomatosis
- Leiomyoma
- Leiomyomatosis peritonealis disseminata
- Mitotically-active leiomyoma
- Myxoid leiomyoma
- Benign tumours of uncertain differentiation
- Acral fibromyxoma
- Brown tumour
- Deep (aggressive) angiomyxoma
- Ectopic hamartomatous thymoma
- Fibrous dysplasia
- Inflammatory fibroid polyp
- Intramuscular myxoma
- Juxta-articular myxoma
- Osteofibrous dysplasia
- Pleomorphic hyalinizing angiectatic tumour
- Rosai-Dorfman disease
- Simple bone cyst
- Superficial angiomyxoma
- Benign vascular tumours
- Angiomatosis
- Epithelioid hemangioma
- Gorham disease
- Hemangioma
- Intra-muscular hemangioma
- Lymphangioma
- Pyogenic granuloma
- Osseous pseudo-tumours
- Bizarre parosteal osteochondromatous proliferation
- Callus
- Florid ossificans periostitis
- Post-traumatic fibro-osseous lesion
- Tophaceous pseudogout
- Other benign lesion
- GIST
- gastrointestinal stromal tumour (GIST), benign
- gastrointestinal stromal tumour (GIST), malignant
- gastrointestinal stromal tumour (GIST), uncertain malignant potential
- Non-mesenchymal malignant tumour
- Carcinoma
- Germinal tumor
- Lymphoma
- Melanoma
- Myeloma
- Other non-mesenchymal malignant tumours
- Plasmocytoma
- Other diagnoses
- Diagnosis unspecified
- Undifferentiated malignant tumour
- Sarcoma
- Chondrosarcoma
- Central chondrosarcoma
- Chondrosarcoma NOS
- Clear cell chondrosarcoma
- Dedifferentiated chondrosarcoma
- Mesenchymal chondrosarcoma
- Periosteal chondrosarcoma
- Peripheral chondrosarcoma
- Leiomyosarcoma
- Leiomyosarcoma - differentiated
- Leiomyosarcoma - poorly-differentiated
- Liposarcoma
- Liposarcoma - dedifferentiated
- Liposarcoma - mixed type
- Liposarcoma - myxoid
- Liposarcoma - NOS
- Liposarcoma - pleomorphic
- Liposarcoma - round cell
- Liposarcoma - well differentiated
- Malignant peripheral nerve sheath tumour
- Ectomesenchymoma
- Malignant perineurioma
- Malignant Triton tumour
- MPNST - epithelioid type
- MPNST - usual type
- Miscellaneous sarcomas
- Adult fibrosarcoma
- Alveolar soft part sarcoma
- Angiosarcoma
- BCOR sarcoma
- CIC-DUX sarcoma
- Clear cell sarcoma
- Desmoplastic round cell tumour
- Epithelioid haemangioendothelioma
- Epithelioid sarcoma
- Ewing sarcoma
- Rhabdoid tumour
- Extraskeletal myxoid chondrosarcoma
- Intimal sarcoma
- Low grade fibromyxoid sarcoma
- Low grade sinonasal sarcoma
- Malignant glomus tumour
- Malignant granular cell sarcoma
- Malignant mesenchymoma
- Malignant mixed tumor
- Malignant ossifying fibromyxoid tumour
- Malignant PECOMA
- Malignant solitary fibrous tumour
- Malignant tenosynovial giant cell tumour
- Myoepithelial carcinoma
- Sclerosing epithelioid fibrosarcoma
- SMARCA4-deficient thoracic sarcoma
- Myxofibrosarcoma
- Osteosarcoma
- Conventional osteosarcoma
- Dedifferentiated low-grade central osteosarcoma
- Dedifferentiated parosteal osteosarcoma
- Extraskeletal osteosarcoma
- High-grade surface osteosarcoma
- Low-grade central osteosarcoma
- Osteoblastoma-like osteosarcoma
- Osteosarcoma NOS
- Parosteal osteosarcoma
- Periosteal osteosarcoma
- Small cell osteosarcoma
- Telangiectasic osteosarcoma
- Other sarcomas
- Adamantinoma
- Adenosarcoma
- Chordoma
- Dedifferentiated adamantimoma
- Dedifferentiated chordoma
- Endometrial stromal sarcoma
- Endometrial stromal sarcoma - high-grade
- Endometrial stromal sarcoma - low-grade
- Endometrial stromal sarcoma - undifferentiated
- Phyllodes sarcoma
- Rhabdomyosarcoma
- Adult spindle cell rhabdomyosarcoma
- Alveolar rhabdomyosarcoma
- Embryonal rhabdomyosarcoma - botryoid type
- Embryonal rhabdomyosarcoma - NOS
- Embryonal rhabdomyosarcoma - spindle cell type
- Embryonal rhabdomyosarcoma - usual type
- Pleomorphic rhabdomyosarcoma
- Rhabdomyosarcoma - NOS
- Sclerosing rhabdomyosarcoma
- Spindle cell rhabdomyosarcoma
- Suspicion of sarcoma
- Synovial sarcoma
- Synovial sarcoma - biphasic
- Synovial sarcoma - monophasic
- Synovial sarcoma - NOS
- Synovial sarcoma - poorly differentiated
- Undifferentiated sarcoma
- Dermal pleomorphic sarcoma
- Undifferentiated epithelioid sarcoma
- Undifferentiated pleomorphic sarcoma
- Undifferentiated round cell sarcoma
- Undifferentiated sarcoma - NOS
- Undifferentiated spindle cell sarcoma
- Tumour of intermediate malignancy
- Atypical lipomatous tumour
- Intermediate chondrogenic tumours
- Atypical cartilaginous Tumour/Chondrosarcoma grade 1
- Cartilaginous tumour of uncertain prognosis
- Chondroblastoma
- Chondromyxoid fibroma
- Intermediate fibroblastic/myofibroblastic tumours
- Dermatofibrosarcoma protuberans
- Desmoid-type fibromatosis
- Desmoplastic fibroma of bone
- Fibro-osseous tumour of bone NOS
- Fibrosarcomatous dermatofibrosarcoma protuberans
- Giant cell fibroblastoma
- Infantile fibrosarcoma
- Inflammatory myofibroblastic tumour
- Lipofibromatosis
- Low grade myofibroblastic sarcoma
- Myxoinflammatory fibroblastic sarcoma
- Palmar/plantar fibromatosis
- Solitary fibrous tumour
- Intermediate fibrohistiocytic tumours
- Giant cell tumour of bone
- Giant cell tumour of soft tissues
- Malignant/dedifferentiated giant cell tumour of bone
- Metastatic giant cell tumour of bone
- Osseous tumour rich in giant cell NOS
- Plexiform fibrohistiocytic tumour
- Suspicion of giant cell tumour of bone
- Intermediate osteogenic tumours
- Osteoblastoma
- Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma)
- Intermediate tumours of uncertain differentiation
- Aneurysmal bone cyst
- Angiomatoid fibrous histiocytoma
- Atypical fibroxanthoma
- Erdheim-Chester disease
- Hemosiderotic fibrolipomatous tumour
- Langerhans cell histiocytosis
- Lymphangioleiomyoma/lymphangioleiomyomatosis
- Melanotic neuroectodermal tumour of infancy
- Mixed tumour
- Myoepithelioma
- Ossifying fibromyxoid tumour
- PECOMA - NOS
- Phosphaturic mesenchymal tumour
- Intermediate vascular tumours
- Composite hemangioendothelioma
- Epitheliod vascular tumour of bone NOS
- Kaposi sarcoma
- Kaposiform hemangioendothelioma
- Papillary intralymphatic angioendothelioma
- Pseudomyogenic hemangioendothelioma
- Retiform hemangioendothelioma
- Lipomatous spindle cell/pleomorphic tumour of malignant potential
- Other tumours of intermediate malignancy
- Endometrial stromal nodule
- Metastatic leiomyoma
- Smooth muscle tumour of undetermined malignant potential (STUMP)
- Uterine tumour resembling ovarian sex cord tumours (UTROSCT)

Date of original diagnosis
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description : Date of the first sampling which allowed the diagnosis of the current tumour

Age at diagnosis
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No
Description :

Diagnosis changed
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Modification de diagnostic (diagnostic redressé) suite à la relecture anapath.<br>Exemple : en 2010 diagnostic de lipome relecture des lames en 2013 diagnostic de liposarcome le diagnostic est redressé donc Diagnosis changed = Yes.<br>Exemple : diagnostic liposarcome bien différencié qui devient après rechute un liposarcome indifférentié. Diagnosis changed = No.<br> Possible values :
No, Yes

Initial diagnosis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Quel était le diagnostic avant que le redressement de diag ? <br> Possible values :
- Benign lesion
- Benign adipocytic tumours
- Angiolipoma
- Angiomyolipoma
- Chondroid lipoma
- Hibernoma
- Lipoblastoma/lipoblastomatosis
- Lipoma
- Lipomatosis
- Lipomatosis of nerve
- Myelolipoma
- Myolipoma
- Spindle cell / pleomorphic lipoma
- Benign chondrogenic tumours
- Chondroma
- Enchondroma
- Osteochondroma
- Osteochondromyxoma
- Periosteal chondroma
- Subungueal exostosis
- Synovial chondromatosis
- Benign fibroblastic/myofibroblastic tumours
- Adenofibroma
- Angiofibroma
- Angiomyofibroblastoma
- Calcifying aponeurotic fibroma
- Calcifying fibrous tumour
- Cellular angiofibroma
- Desmoplastic fibroblastoma
- Elastofibroma
- Fasciitis
- Fibro-osseous pseudotumour of digits
- Fibroma of tendon sheath
- Fibromatosis colli
- Fibrous hamartoma of infancy
- Gardner fibroma
- Inclusion body fibromatosis
- Intra-nodal palisaded myofibroblastoma
- Ischaemic fasciitis
- Juvenile hyaline fibromatosis
- Mammary-type myofibroblastoma
- Myositis ossificans
- Nasopharyngeal angiofibroma
- Nodular fasciitis
- Nuchal-type fibroma
- Organ-associated pseudosarcomatous myofibroblastic proliferations
- Other fibromas
- Proliferative fasciitis
- Proliferative myositis
- Benign fibro-histiocytic tumours
- Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws)
- Deep benign fibrous histiocytoma
- Fibrous histiocytoma
- Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma)
- Non Ossifying fibroma
- Tenosynovial giant cell tumour
- Tenosynovial giant cell tumour, diffuse type
- Tenosynovial giant cell tumour, localized type
- Benign nerve sheath tumours
- Benign Triton tumour
- Dermal nerve sheath myxoma
- Ectopic meningioma
- Granular cell tumour
- Hybrid nerve sheath tumours
- Melanotic schwannoma
- Nasal glial heterotopia
- Neurofibroma
- Neurothekeoma
- Perineurioma
- Plexiform neurofibroma
- Schwannoma
- Solitary circumscribed neuroma
- Benign notochordal tumour
- Benign osteogenic tumours
- Osteoid osteoma
- Osteoma
- Benign pericytic tumours
- Angioleiomyoma
- Glomus tumour
- Myofibroma / myofibromatosis
- Myopericytoma
- Benign skeletal muscle tumours
- Rhabdomyoma
- Rhabdomyoma - adult type
- Rhabdomyoma - fetal type
- Rhabdomyoma - genital type
- Benign smooth muscle tumours
- Atypical polypoid adenomyoma
- Bizarre nuclei leiomyoma
- Cellular leiomyoma
- Diffuse leiomyomatosis
- Dissecans leiomyoma
- Epithelioid leiomyoma
- Intraveinous leiomyomatosis
- Leiomyoma
- Leiomyomatosis peritonealis disseminata
- Mitotically-active leiomyoma
- Myxoid leiomyoma
- Benign tumours of uncertain differentiation
- Acral fibromyxoma
- Brown tumour
- Deep (aggressive) angiomyxoma
- Ectopic hamartomatous thymoma
- Fibrous dysplasia
- Inflammatory fibroid polyp
- Intramuscular myxoma
- Juxta-articular myxoma
- Osteofibrous dysplasia
- Pleomorphic hyalinizing angiectatic tumour
- Rosai-Dorfman disease
- Simple bone cyst
- Superficial angiomyxoma
- Benign vascular tumours
- Angiomatosis
- Epithelioid hemangioma
- Gorham disease
- Hemangioma
- Intra-muscular hemangioma
- Lymphangioma
- Pyogenic granuloma
- Osseous pseudo-tumours
- Bizarre parosteal osteochondromatous proliferation
- Callus
- Florid ossificans periostitis
- Post-traumatic fibro-osseous lesion
- Tophaceous pseudogout
- Other benign lesion
- GIST
- gastrointestinal stromal tumour (GIST), benign
- gastrointestinal stromal tumour (GIST), malignant
- gastrointestinal stromal tumour (GIST), uncertain malignant potential
- Non-mesenchymal malignant tumour
- Carcinoma
- Germinal tumor
- Lymphoma
- Melanoma
- Myeloma
- Other non-mesenchymal malignant tumours
- Plasmocytoma
- Other diagnoses
- Diagnosis unspecified
- Undifferentiated malignant tumour
- Sarcoma
- Chondrosarcoma
- Central chondrosarcoma
- Chondrosarcoma NOS
- Clear cell chondrosarcoma
- Dedifferentiated chondrosarcoma
- Mesenchymal chondrosarcoma
- Periosteal chondrosarcoma
- Peripheral chondrosarcoma
- Leiomyosarcoma
- Leiomyosarcoma - differentiated
- Leiomyosarcoma - poorly-differentiated
- Liposarcoma
- Liposarcoma - dedifferentiated
- Liposarcoma - mixed type
- Liposarcoma - myxoid
- Liposarcoma - NOS
- Liposarcoma - pleomorphic
- Liposarcoma - round cell
- Liposarcoma - well differentiated
- Malignant peripheral nerve sheath tumour
- Ectomesenchymoma
- Malignant perineurioma
- Malignant Triton tumour
- MPNST - epithelioid type
- MPNST - usual type
- Miscellaneous sarcomas
- Adult fibrosarcoma
- Alveolar soft part sarcoma
- Angiosarcoma
- BCOR sarcoma
- CIC-DUX sarcoma
- Clear cell sarcoma
- Desmoplastic round cell tumour
- Epithelioid haemangioendothelioma
- Epithelioid sarcoma
- Ewing sarcoma
- Rhabdoid tumour
- Extraskeletal myxoid chondrosarcoma
- Intimal sarcoma
- Low grade fibromyxoid sarcoma
- Low grade sinonasal sarcoma
- Malignant glomus tumour
- Malignant granular cell sarcoma
- Malignant mesenchymoma
- Malignant mixed tumor
- Malignant ossifying fibromyxoid tumour
- Malignant PECOMA
- Malignant solitary fibrous tumour
- Malignant tenosynovial giant cell tumour
- Myoepithelial carcinoma
- Sclerosing epithelioid fibrosarcoma
- SMARCA4-deficient thoracic sarcoma
- Myxofibrosarcoma
- Osteosarcoma
- Conventional osteosarcoma
- Dedifferentiated low-grade central osteosarcoma
- Dedifferentiated parosteal osteosarcoma
- Extraskeletal osteosarcoma
- High-grade surface osteosarcoma
- Low-grade central osteosarcoma
- Osteoblastoma-like osteosarcoma
- Osteosarcoma NOS
- Parosteal osteosarcoma
- Periosteal osteosarcoma
- Small cell osteosarcoma
- Telangiectasic osteosarcoma
- Other sarcomas
- Adamantinoma
- Adenosarcoma
- Chordoma
- Dedifferentiated adamantimoma
- Dedifferentiated chordoma
- Endometrial stromal sarcoma
- Endometrial stromal sarcoma - high-grade
- Endometrial stromal sarcoma - low-grade
- Endometrial stromal sarcoma - undifferentiated
- Phyllodes sarcoma
- Rhabdomyosarcoma
- Adult spindle cell rhabdomyosarcoma
- Alveolar rhabdomyosarcoma
- Embryonal rhabdomyosarcoma - botryoid type
- Embryonal rhabdomyosarcoma - NOS
- Embryonal rhabdomyosarcoma - spindle cell type
- Embryonal rhabdomyosarcoma - usual type
- Pleomorphic rhabdomyosarcoma
- Rhabdomyosarcoma - NOS
- Sclerosing rhabdomyosarcoma
- Spindle cell rhabdomyosarcoma
- Suspicion of sarcoma
- Synovial sarcoma
- Synovial sarcoma - biphasic
- Synovial sarcoma - monophasic
- Synovial sarcoma - NOS
- Synovial sarcoma - poorly differentiated
- Undifferentiated sarcoma
- Dermal pleomorphic sarcoma
- Undifferentiated epithelioid sarcoma
- Undifferentiated pleomorphic sarcoma
- Undifferentiated round cell sarcoma
- Undifferentiated sarcoma - NOS
- Undifferentiated spindle cell sarcoma
- Tumour of intermediate malignancy
- Atypical lipomatous tumour
- Intermediate chondrogenic tumours
- Atypical cartilaginous Tumour/Chondrosarcoma grade 1
- Cartilaginous tumour of uncertain prognosis
- Chondroblastoma
- Chondromyxoid fibroma
- Intermediate fibroblastic/myofibroblastic tumours
- Dermatofibrosarcoma protuberans
- Desmoid-type fibromatosis
- Desmoplastic fibroma of bone
- Fibro-osseous tumour of bone NOS
- Fibrosarcomatous dermatofibrosarcoma protuberans
- Giant cell fibroblastoma
- Infantile fibrosarcoma
- Inflammatory myofibroblastic tumour
- Lipofibromatosis
- Low grade myofibroblastic sarcoma
- Myxoinflammatory fibroblastic sarcoma
- Palmar/plantar fibromatosis
- Solitary fibrous tumour
- Intermediate fibrohistiocytic tumours
- Giant cell tumour of bone
- Giant cell tumour of soft tissues
- Malignant/dedifferentiated giant cell tumour of bone
- Metastatic giant cell tumour of bone
- Osseous tumour rich in giant cell NOS
- Plexiform fibrohistiocytic tumour
- Suspicion of giant cell tumour of bone
- Intermediate osteogenic tumours
- Osteoblastoma
- Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma)
- Intermediate tumours of uncertain differentiation
- Aneurysmal bone cyst
- Angiomatoid fibrous histiocytoma
- Atypical fibroxanthoma
- Erdheim-Chester disease
- Hemosiderotic fibrolipomatous tumour
- Langerhans cell histiocytosis
- Lymphangioleiomyoma/lymphangioleiomyomatosis
- Melanotic neuroectodermal tumour of infancy
- Mixed tumour
- Myoepithelioma
- Ossifying fibromyxoid tumour
- PECOMA - NOS
- Phosphaturic mesenchymal tumour
- Intermediate vascular tumours
- Composite hemangioendothelioma
- Epitheliod vascular tumour of bone NOS
- Kaposi sarcoma
- Kaposiform hemangioendothelioma
- Papillary intralymphatic angioendothelioma
- Pseudomyogenic hemangioendothelioma
- Retiform hemangioendothelioma
- Lipomatous spindle cell/pleomorphic tumour of malignant potential
- Other tumours of intermediate malignancy
- Endometrial stromal nodule
- Metastatic leiomyoma
- Smooth muscle tumour of undetermined malignant potential (STUMP)
- Uterine tumour resembling ovarian sex cord tumours (UTROSCT)

Date of review
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description : Date à laquelle la relecture anapath a permis de redresser le diagnostic. <br>

Grade of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Histologic grade of the primary tumour according to the French grading system: tumour differentiation score 1 to 3, 0) + mitotic index (score 1 to 3, 0) + tumour necrosis (score 0 to 2, 0) Grade=1 for total score of 2 or 3 Grade=2 for total score of 4 or 5 Grade=3 for total score of 6, 7 or 8 Possible values :
1, 2, 3, NA

Miettinen/AFIP
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Risque de malignité des GIST selon Miettinen Possible values :
Very low risk, Low risk, Intermediate risk, High risk, NA

Mutation (GIST)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Y a-t-il eu une recherche de mutation de faite ?<br>Réponse possible : <br>Non<br>Oui et le résultat est positif<br>Oui et le résultat est négatif<br>Oui et le résultat n'est pas interprétable.<br> Possible values :
No, Yes positive, Yes negative, Yes not interpretable

Radiation area
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Yes : tumour developed in a previously irradiated area Possible values :
No, Yes

M
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Yes when there is a distant metastasis diagnosed by imaging and / or histological evaluation Possible values :
Yes, No, Skip

ImagingBeforeTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No
Description : Possible values :
No, Ultrasound, CT Scan, MRI, X-Ray (standard radiograph), Other, Not available

Type of biopsy
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Type de biopsie à visée de diagnostic avant la chirurgie.<br>Open biopsy : biopsie chirurgicale ou incisionnelle<br>Biopsy NOS : Biopsie SAI<br>Not available : Information non disponible Possible values :
No, Microbiopsy, Open biopsy, Biopsy NOS, Microbiopsy and open biopsy, Cytology only, Not available

Neo-adj ttt before surgery
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Traitement néo-adjuvant avant la chirurgie Possible values :
Yes, No

RCP planned surgery quality
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : La qualité de la chirurgie a-t-elle été prévue par une des RCP précédant la chirurgie.? Possible values :
Yes, No

Surgery of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Possible values :
No, Yes, Curettage

Date of surgery
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description : Date of surgery

Surgeon
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Chirurgien qui a opéré la tumeur primaire<br>Les chirurgiens Sarcome sont listés dans Network.<br>Si la RCP propose que l'opération soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network.<br>Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.<br> Possible values :
- Network
- ALIFANO Marco (Paris)
- ANRACT Philippe (Paris)
- BABINET Antoine (Paris)
- BALLAS Richard (La Reunion)
- BAQUE Patrick (Nice)
- BASSELOT Frédéric (Rennes)
- BERGER Anne (Paris)
- BIAU David (Paris)
- BLONDET Remi (Lyon)
- BODIN Frédéric (Strasbourg)
- BONNEVIALLE Paul (Toulouse)
- BONVALOT Sylvie (Paris)
- BRIAND Sylvain (Nantes)
- BRINKERT David (Strasbourg)
- BROUCHET Laurent (Toulouse)
- BRUCHON Yvonnic (Dijon)
- BRULEFERT Kevin (Nantes)
- CARRERE Sebastien (Montpellier)
- CARRET Jean-Paul (Lyon)
- CAUSERET Sylvain (Dijon)
- CAVALCANTI Andrea (Villejuif)
- CHAMMAS Michel (Montpellier)
- CHAPELIER Alain (Paris)
- CHOTEL Franck (Lyon)
- COLOMBO Emmanuel (Montpellier)
- COSTAZ Hélène (Dijon)
- COURT Charles (Villejuif)
- COUTANT Charles (Dijon)
- COUTURAUD Benoit (Paris)
- CRENN Vincent (Nantes)
- CUISENIER Jean (Dijon)
- CURVALE Georges (Marseille)
- DAUTEL Gilles (Nancy)
- DE BILLY Benoit (Besançon)
- DECANTER Gauthier (Lille)
- DELROEUX Delphine (Besancon)
- DESFOURNEAUX Véronique (Rennes)
- DESOLNEUX Grégoire (Bordeaux)
- DIDELOT Stéphane (Montpellier)
- DI MARCO Antonio (Strasbourg)
- DOUSSET Bertrand (Paris)
- DUJARDIN Franck (Rouen)
- DUMAINE Valérie (Paris)
- DUNET Julien (Caen)
- DUPRE Aurelien (Lyon)
- ENKAOUA Eric (Paris)
- EVEN Julien (Paris)
- FABRE Thierry (Bordeaux)
- FAKHRY Nicolas (Marseille)
- FARON Matthieu (Villejuif)
- FAU Magali (Nancy)
- FERRON Gwenael (Toulouse)
- FIORENZA Fabrice (Limoges)
- FOUCHE Yves (Nice)
- FRAISSE Bernard (Rennes)
- FRAISSE Jean (Dijon)
- FRON Damien (Lille)
- FUENTES Stephane (Marseille)
- GANGLOFF Dimitri (Toulouse)
- GARRET Jérome (Lyon)
- GAY André (Marseille)
- GHOUTI Laurent (Toulouse)
- GICQUEL Philippe (Strasbourg)
- GILLERON Matthieu (Rouen)
- GILLES Olivier (Bordeaux)
- GIMBERGUES Pierre (Clermond-Ferrand)
- GOUIN Francois (Nantes)
- GUILLEMIN François (Reims)
- GUILLOIT Jean-Marc (Caen)
- GUINARD Didier (Marseille)
- GUIRAMAND Jerome (Marseille)
- GUYARD Matthieu (Lyon)
- HAMEL Antoine (Nantes)
- HAMEURY Frederic (Lyon)
- HARDWIGSEN Jean (Marseille)
- HARNOY Yann (Rennes)
- HONORE Charles (Villejuif)
- IHRAI Tarik (Nice)
- JACOPIN Samuel (La Reunion)
- JAFARI Mehrdad (Lille)
- JANKOWSKI Clémentine (Dijon)
- JEGOUX Franck (Rennes)
- JOUVE Jean-Luc (Marseille)
- LAFFOSSE Jean-Michel (Toulouse)
- LAVOUE Vincent (Rennes)
- LAZERGES Cyril (Montpellier)
- LE NAIL Louis-Romée (Tours)
- MACHIAVELLO Jean-Christophe (Nice)
- MARCHAL Frédéric (Nancy)
- MARCO Oren (Paris)
- MARIANI Pascale (Paris)
- MARY Pierre (Paris)
- MASCARD Eric (Paris)
- MATTEI Jean-Camille (Marseille)
- MAURY Philippe (Montpellier)
- MAYNOU Carlos (Lille)
- MEEUS Pierre (Lyon)
- MEGY Bernard (Nimes)
- MENSA Christophe (Reims)
- MERESSE Thomas (Toulouse)
- MEUNIER Bernard (Rennes)
- MEZEL Aurélie (Lille)
- MICHEL Jean-Luc (La Reunion)
- MICHOT Audrey (Bordeaux)
- MIGAUD Henri (Lille)
- MISSENARD Gilles (Villejuif)
- MOUSSELARD Pascal (Paris)
- ORRY David (Dijon)
- OZIL Camille (Paris)
- PADEANO Marie-Martine (Dijon)
- PANNIER Stéphanie (Paris)
- PAUCHOT Julien (Besancon/Clermont2018)
- PEYRAT Patrice (Lyon)
- PLUVY Isabelle (Besancon)
- POLYCARPE Emmanuel (Caen)
- POP Daniel (Nice)
- QUENET François (Montpellier)
- RAUX Sebastien (Lyon)
- REGENET Nicolas (Nantes)
- REVOL Marc (Paris)
- RICHARD DE LA TOUR Bertrand (Rennes)
- RIMAREIX Francoise (Villejuif)
- RIVOIRE Michel (Lyon)
- ROCHCONGAR Goulven (Caen)
- ROCHWERGER Alexandre (Marseille)
- ROPARS Mickael (Rennes)
- ROSSET Philippe (Tours)
- ROUANET Philippe (Montpellier)
- RUZIC Jean-Christophe (La Reunion)
- SAUVAT Frédérique (La Reunion)
- SIRVEAUX François (Nancy)
- STOECKLE Eberhard (Bordeaux)
- SULPICE Laurent (Rennes)
- SZYMANSKI Christophe (Lille)
- TABUTIN Mayeul (Lyon)
- TEMAM Stéphane (Villejuif)
- TESSIER William (Lille)
- THEVENIN-LEMOINE Camille (Toulouse)
- THOMAS Pascal (Marseille)
- THOULOUZAN Mathieu (Toulouse)
- TZANIS Dimitrios (Paris)
- VALLEE Antoine (Rouen)
- VAZ Gualter (Lyon)
- VERHAEGHE Jean-Luc (Nancy)
- VIARD Brice (Dijon)
- VINCELET Yannick (Nancy)
- VIOLAS Philippe (Rennes)
- WAAST Denis (Nantes)
- Referral to a specialized surgery outside network
- Outside network

Quality of 1st surgery
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Qualité de la première chirurgie de la tumeur primaire.<br>R0 : résection macroscopiquement pour le chirugien&nbsp;et microscopiquement complète pour l'anapath. Résection monobloc.&nbsp;(Tumeur non vue lors de la chirurgie) <br>R1 : résection macroscopiquement complète&nbsp;&nbsp;Si le chirurgien a vu la tumeur la résection sera au mieux R1.<br>R2 : Résection incomplète, énucléation. Possible values :
R0 margin, R1 margin, R2 margin, Margin not evaluable, Unknown

Re-excision
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Reprise chirurgicale tumeur primaire<br>Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.<br><br> Possible values :
No, Yes, Curettage

Re-excision surgeon
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Chirurgien qui a ré-opéré la tumeur primaire<br>Les chirurgiens sarcome sont listés dans Network.<br>Si la RCP propose que la reprise soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network.<br>Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network. Possible values :
- Network
- ALIFANO Marco (Paris)
- ANRACT Philippe (Paris)
- BABINET Antoine (Paris)
- BALLAS Richard (La Reunion)
- BAQUE Patrick (Nice)
- BASSELOT Frédéric (Rennes)
- BERGER Anne (Paris)
- BIAU David (Paris)
- BLONDET Remi (Lyon)
- BODIN Frédéric (Strasbourg)
- BONNEVIALLE Paul (Toulouse)
- BONVALOT Sylvie (Paris)
- BRIAND Sylvain (Nantes)
- BRINKERT David (Strasbourg)
- BROUCHET Laurent (Toulouse)
- BRUCHON Yvonnic (Dijon)
- BRULEFERT Kevin (Nantes)
- CARRERE Sebastien (Montpellier)
- CARRET Jean-Paul (Lyon)
- CAUSERET Sylvain (Dijon)
- CAVALCANTI Andrea (Villejuif)
- CHAMMAS Michel (Montpellier)
- CHAPELIER Alain (Paris)
- CHOTEL Franck (Lyon)
- COLOMBO Emmanuel (Montpellier)
- COSTAZ Hélène (Dijon)
- COURT Charles (Villejuif)
- COUTANT Charles (Dijon)
- COUTURAUD Benoit (Paris)
- CRENN Vincent (Nantes)
- CUISENIER Jean (Dijon)
- CURVALE Georges (Marseille)
- DAUTEL Gilles (Nancy)
- DE BILLY Benoit (Besançon)
- DECANTER Gauthier (Lille)
- DELROEUX Delphine (Besancon)
- DESFOURNEAUX Véronique (Rennes)
- DESOLNEUX Grégoire (Bordeaux)
- DIDELOT Stéphane (Montpellier)
- DI MARCO Antonio (Strasbourg)
- DOUSSET Bertrand (Paris)
- DUJARDIN Franck (Rouen)
- DUMAINE Valérie (Paris)
- DUNET Julien (Caen)
- DUPRE Aurelien (Lyon)
- ENKAOUA Eric (Paris)
- EVEN Julien (Paris)
- FABRE Thierry (Bordeaux)
- FAKHRY Nicolas (Marseille)
- FARON Matthieu (Villejuif)
- FAU Magali (Nancy)
- FERRON Gwenael (Toulouse)
- FIORENZA Fabrice (Limoges)
- FOUCHE Yves (Nice)
- FRAISSE Bernard (Rennes)
- FRAISSE Jean (Dijon)
- FRON Damien (Lille)
- FUENTES Stephane (Marseille)
- GANGLOFF Dimitri (Toulouse)
- GARRET Jérome (Lyon)
- GAY André (Marseille)
- GHOUTI Laurent (Toulouse)
- GICQUEL Philippe (Strasbourg)
- GILLERON Matthieu (Rouen)
- GILLES Olivier (Bordeaux)
- GIMBERGUES Pierre (Clermond-Ferrand)
- GOUIN Francois (Nantes)
- GUILLEMIN François (Reims)
- GUILLOIT Jean-Marc (Caen)
- GUINARD Didier (Marseille)
- GUIRAMAND Jerome (Marseille)
- GUYARD Matthieu (Lyon)
- HAMEL Antoine (Nantes)
- HAMEURY Frederic (Lyon)
- HARDWIGSEN Jean (Marseille)
- HARNOY Yann (Rennes)
- HONORE Charles (Villejuif)
- IHRAI Tarik (Nice)
- JACOPIN Samuel (La Reunion)
- JAFARI Mehrdad (Lille)
- JANKOWSKI Clémentine (Dijon)
- JEGOUX Franck (Rennes)
- JOUVE Jean-Luc (Marseille)
- LAFFOSSE Jean-Michel (Toulouse)
- LAVOUE Vincent (Rennes)
- LAZERGES Cyril (Montpellier)
- LE NAIL Louis-Romée (Tours)
- MACHIAVELLO Jean-Christophe (Nice)
- MARCHAL Frédéric (Nancy)
- MARCO Oren (Paris)
- MARIANI Pascale (Paris)
- MARY Pierre (Paris)
- MASCARD Eric (Paris)
- MATTEI Jean-Camille (Marseille)
- MAURY Philippe (Montpellier)
- MAYNOU Carlos (Lille)
- MEEUS Pierre (Lyon)
- MEGY Bernard (Nimes)
- MENSA Christophe (Reims)
- MERESSE Thomas (Toulouse)
- MEUNIER Bernard (Rennes)
- MEZEL Aurélie (Lille)
- MICHEL Jean-Luc (La Reunion)
- MICHOT Audrey (Bordeaux)
- MIGAUD Henri (Lille)
- MISSENARD Gilles (Villejuif)
- MOUSSELARD Pascal (Paris)
- ORRY David (Dijon)
- OZIL Camille (Paris)
- PADEANO Marie-Martine (Dijon)
- PANNIER Stéphanie (Paris)
- PAUCHOT Julien (Besancon/Clermont2018)
- PEYRAT Patrice (Lyon)
- PLUVY Isabelle (Besancon)
- POLYCARPE Emmanuel (Caen)
- POP Daniel (Nice)
- QUENET François (Montpellier)
- RAUX Sebastien (Lyon)
- REGENET Nicolas (Nantes)
- REVOL Marc (Paris)
- RICHARD DE LA TOUR Bertrand (Rennes)
- RIMAREIX Francoise (Villejuif)
- RIVOIRE Michel (Lyon)
- ROCHCONGAR Goulven (Caen)
- ROCHWERGER Alexandre (Marseille)
- ROPARS Mickael (Rennes)
- ROSSET Philippe (Tours)
- ROUANET Philippe (Montpellier)
- RUZIC Jean-Christophe (La Reunion)
- SAUVAT Frédérique (La Reunion)
- SIRVEAUX François (Nancy)
- STOECKLE Eberhard (Bordeaux)
- SULPICE Laurent (Rennes)
- SZYMANSKI Christophe (Lille)
- TABUTIN Mayeul (Lyon)
- TEMAM Stéphane (Villejuif)
- TESSIER William (Lille)
- THEVENIN-LEMOINE Camille (Toulouse)
- THOMAS Pascal (Marseille)
- THOULOUZAN Mathieu (Toulouse)
- TZANIS Dimitrios (Paris)
- VALLEE Antoine (Rouen)
- VAZ Gualter (Lyon)
- VERHAEGHE Jean-Luc (Nancy)
- VIARD Brice (Dijon)
- VINCELET Yannick (Nancy)
- VIOLAS Philippe (Rennes)
- WAAST Denis (Nantes)
- Referral to a specialized surgery outside network
- Outside network

Quality of re-excision
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Qualité de la reprise chirurgicale de la tumeur primaire.<br>R0 margin no tumour was found : pas de reliquat tumoral retrouvé par l'anapath dans la pièce opératoire.<br>R0 margin and tumour was found : présence d'un reliquat tumoral et résection microscopiquement complète.<br>R1 margin and tumour was found : reliquat présent et résection macroscopiquement complète.<br>R2 margin and tumour was found : reliquat présent et résection incomplète.<br>Margin not evaluable : l'anapath dit que les marges ne sont pas évaluables.<br> Possible values :
R0 margin no tumour was found, R0 margin and tumour was found, R1 margin and tumour was found, R2 margin and tumour was found, Margin not evaluable, Unknown

Fragmented tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : La tumeur est arrivée en plusieurs fragments chez l'anapath Possible values :
Yes, No, NA

Tumour spillage (CTCB)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Expert pathologist observed if the tumour was spilt Possible values :
Yes, No

Progression
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Prend en compte la première progression locale et la première progression métastatique. Si elles sont simultannées les 2 dates sont identiques sinon elles sont différentes. Possible values :
No, Local, Metastatic, Local and metastatic, Not specify

Date 1st local progression
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description :

Date 1st metastatic progression
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description :

RCP (12 items)


File number
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Numéro de dossier du patient dans votre établissement <br>

Date RCP
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description : Date de la RCP<br>

Centre of RCP
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Centre de RCP<br> Possible values :
- CIRTAL National RCP
- Adult Regional RCP
- RCP Besançon
- RCP Bordeaux
- RCP Caen
- RCP Clermont-Ferrand
- RCP Dijon
- RCP Dom Tom La Réunion
- RCP Lille
- RCP Limoges
- RCP Lyon
- RCP Marseille IPC
- RCP Marseille Timone
- RCP Montpellier
- RCP Nancy
- RCP Nantes/Angers
- RCP Nice
- RCP Paris APHP multisites GIST
- RCP Paris Cochin
- RCP Paris Curie
- RCP Paris Pitié Salpetrière
- RCP Paris Saint Louis
- RCP Paris Tenon
- RCP Reims Debré GIST
- RCP Reims Godinot
- RCP Rennes/Brest
- RCP Rouen
- RCP Strasbourg
- RCP Toulouse
- RCP Tours
- RCP Villejuif
- Adult Inter Regional RCP
- RCP IR Lille Caen Rouen Amiens
- RCP IR Bordeaux Limoges Montpellier Toulouse
- RCP IR Nantes Angers Rennes
- RCP IR Grand Est (Nancy, Besancon, Dijon, Reims, Strasbourg)
- Pediatric Inter Regional RCP
- RCP pediatric Est (Besancon,Dijon,Nancy,Reims,Strasbourg)
- RCP pediatric Grand Ouest (Angers,Brest,Caen,Nantes,Poitiers,Rennes,Tours)
- RCP pediatric Ile de France/La Reunion
- RCP pediatric Nord (Amiens,Lille,Rouen)
- RCP pediatric Rhone-Alpes/Auvergne (Clermont-Ferrand,Grenoble, Lyon, Saint-Etienne)
- RCP pediatric Sud Est (Marseille,Montpellier,Nice)
- RCP pediatric Sud Ouest (Bordeaux,Limoges,Toulouse)

Clinical situation
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Situation de la prise en charge du patient lors de la RCP Si un patient a progressé il sera toujours en After progresssion pour toutes les RCP suivantes Possible values :
Before biopsy, Before neo-adjuvant treatment, Before surgery, Complementary treatment, After treatment, After progression

Decision 1
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Possible values :
- Indication for biopsy
- Indication for staging
- Indication for histological review
- Indication for surgery
- Indication for initial tumour surgery
- Indication for metastasis surgery
- Chemoembolisation
- Radiofrequency
- Cryotherapy
- Indication for re-excision
- Indication for ILP
- No indication for surgery
- Indication for radiotherapy
- Indication for neoadjuvant radiothérapy
- Indication for adjuvant radiotherapy
- Indication for exclusive or palliative radiotherapy
- No indication for radiothérapy
- Indication for chemotherapy
- Indication for neoadjuvant chemotherapy
- Indication for adjuvant chemotherapy
- Indication for metastatic chemotherapy
- Targeted therapies
- Continuation of chemotherapy protocol
- Modification of chemotherapy dose
- Modification of chemotherapy protocol
- No indication for chemotherapy
- Supportive or palliative care
- Indication for hormone therapy
- NSAI
- Others
- No indication for additional treatment
- Request for supplementary examinations
- Indication for surveillance program
- Advisory opinion from another MCB
- Advisory opinion from other specialists
- Medical file to present (again) to a MCB

Decision 2
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Possible values :
- Indication for biopsy
- Indication for staging
- Indication for histological review
- Indication for surgery
- Indication for initial tumour surgery
- Indication for metastasis surgery
- Chemoembolization
- Radiofrequency
- Cryotherapy
- Indication for re-excision
- Indication for ILP
- No indication for surgery
- Indication for radiotherapy
- Indication for neoadjuvant radiotherapy
- Indication for adjuvant radiotherapy
- Indication for exclusive or palliative radiotherapy
- No indication for radiotherapy
- Indication for chemotherapy
- Indication for neoadjuvant chemotherapy
- Indication for adjuvant chemotherapy
- Indication for metastatic chemotherapy
- Targeted therapies
- Continuation of chemotherapy protocol
- Modification of chemotherapy dose
- Modification of chemotherapy protocol
- No indication for chemotherapy
- Supportive or palliative care
- Indication for hormone therapy
- NSAI
- Others
- No indication for additional treatment
- Request for supplementary examinations
- Indication for surveillance program
- Advisory opinion from another MCB
- Advisory opinion from other specialists
- Medical file to present (again) to a MCB

Decision 3
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Possible values :
- Indication for biopsy
- Indication for staging
- Indication for histological review
- Indication for surgery
- Indication for initial tumour surgery
- Indication for metastasis surgery
- Chemoembolisation
- Radiofrequency
- Cryotherapy
- Indication for re-excision
- Indication for ILP
- No indication for surgery
- Indication for radiotherapy
- Indication for neoadjuvant radiotherapy
- Indication for adjuvant radiotherapy
- Indication for exclusive or palliative radiotherapy
- No indication for radiotherapy
- Indication for chemotherapy
- Indication for neoadjuvant chemotherapy
- Indication for adjuvant chemotherapy
- Indication for metastatic chemotherapy
- Targeted therapies
- Continuation of chemotherapy protocol
- Modification of chemotherapy dose
- Modification of chemotherapy protocol
- No indication of chemotherapy
- Supportive or palliative care
- Indication for hormone therapy
- NSAI
- Others
- No indication for additional treatment
- Request for supplementary examinations
- Indication for surveillance program
- Advisory opinion from another MCB
- Advisory opinion from other specialists
- Medical file to present (again) to a MCB

Requesting center
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Établissement ou personne (médecin généraliste) adressant le patient en RCP<br> Possible values :
Attending physician, Comprehensive Cancer Center, Universitary Hospital, General Hospital, PSPH, Private institution

CT enrollment Proposal
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Essais clinique proposé par la RCP<br> Possible values :
Yes, No

CtEnrollmentComment
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : CT enrollment comment

Comment
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description :

Comment
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description :

Trial inclusion (5 items)


File number
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Numéro de dossier du patient dans votre établissement

Inclusion date
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No
Description : Date de l'inclusion dans l'essai clinique (signature du consentement)<br>

Clinical trial
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Essai Clinique dans lequel le patient est inclus<br> Possible values :
RT-SU, Other, PAL ANGI 3, SYNFRIZZ, LMS-02, TRUST 62091 EORTC, PAZOGIST, T-DIS-1001, CASSANDRE-1108, APLIPO, ANGIONEXT 0710, LMS-03 (Sarcome 11), DESMOPAZ, ANGIOTAX-PLUS-0906, TOMOREP, FIBROMATOSE WS-RT, DFSP-PAZO, OS II TTP, AcSé Crizotinib, VIT 0910, REGOSARC-1214, CHONDROG, ESTIM LBH, RMS 2005, NRSTS 2005 EPSSG, OS 2006 (Sarcome 9), STRASS 62092 EORTC, Euro-Ewing 99 (Sarcome 1 - EORTC 62981), API-AI (Sarcome 3), 08 SARC 01 (RT-Sarc), SARC-GYN 1, PALSAR II 98 (Sarcome 2), TEPOSSE, ANGI-HE-1110, OUTC'S, GENEWING, SARI, ProActYon, RETROSPECTYON, ISKS , PROFILER, POLY NCR3-TNF GIST, SARCOLIGO, TKI-CPK-1003, IFOS-1, SAKK 56-07, Sarcome 07/0410 (Sarcome 7), Sarcome 04/0205 (Sarcome 4), Sarcome 08/0411 EORTC 62024 (Sarcome 8), EORTC 90061, EORTC 62061, BFR14, SURGIST Sarcome 10/0805 62063 (Sarcome 10), EORTC 62012, EUROSARC ISG-STS 10-01, CREATE EORTC 90101, GOG 0277 / EORTC 55116-62114, ImadGIST, CABONE, CHONRAD, ALDOXORUBICIN-P3-STS-01, EORTC 1202, REGOBONE, EORTC-62113-55115-STBSG-GCG, CYCLIGIST, EORTC 62005, EORTC 62011, EORTC 62991-22998, EORTC 62022, RAPIRI, BERNIE BO20924, TED12318, CSTI571X2103, NBTXR3, CSTI571X2101-BKM120, NP28021, PeComa, DOVIGIST, AB07001, VE-BASKET, AB11002, E7389-G000-309 ESAI, AB04030, Y-Image, PALETTE VEG110727 62072, VEG105430 GW786034, PO4720, E7389-E044-207 / EORTC 62052, A6181112, A6181004, A6181047, SUCCEED AP 23573-07-32, H3E-EW-S115, CAMN 107 A2103, CAMN 107 A2201, CAMN 107 G2301, CAMN 107 DDE06, CSTI571 JDE74, AMG162 2004-2006, EPIGIST, EFC 10145, SARC 011 N021157, ET-C-002-07, SABINE, AMG 655 20060324, ET-B-028-06, ET743-OVC-1001, CP13-0707, NP22890, OP690, PICASSO IPM 3001, BAY 73-4506/14874, IPI-926-04, NO21280, NGR-hTNF NGR 016, ET-B008-98 ET743, CSTI571 0203 EORTC 62001-16003 , CRAD001C 2206 , ET743-STS-201 , AB04016, ET743-SAR-1001 , 62043 EORTC, MORAb-004, TH-CR-406 / SARC 021, BP27772, A6181196, BRF 117019 , A4021020, ATRIGE, ZALYPSIS PM104-B-003-10, NBTXR3 301, LDE225, GENSARC, PVNS, VERSATIS faisabilité, NFITOR, NUTLIN 3 - MDM-2 - RO5503781, LEE011 phase I/II liposarcome, LEE011 phase I tumeurs solides, TSAR, CHDM201X2103C, Euro Ewing 2012, PEMBROSARC, SBRT Pédiatrie, ICGC LEIOMYOSARCOMES GSF, BP29428, MARGIC : Evaluation médico-économique, CCGM097X2101, GENMODIF, EQUIMETH2, HEPATOFLUO, MOST (My Own Specific Therapy), SHIVA - Phase II Preuve de concept, MOZOBIL15609 , SALTO-BIO , SALTO-2, SALTO, PACIFIK- GP28153, ABI-007-PST-001 - pédiatrie, KF5503-66, PROSPECTYON, AMG 232, rEECur EORTC 1403: sarcome d'Ewing, GC-BIO-IPC 2013-010, PERMED01-IPC 2014-003, ALTITUDES-1508 , RADIOSARP, PROPAN01, MorphinOgel, GEIS-32 , BLU-285-1101, EZH-202 , PLX108-10, OTMRG, GO28399, ALT GIST, MEME, CRYODESMO, MAPPYACTS, MO29518 BASKET, TRASTS, GIGIST-LB, I5B-MC-JGDJ : ANNOUNCE Ph III, I5B-MC-JGDM , MOTION - méta osseuses - Cryoablation, FIVE PRIME FPA008-002, AcSé-eSMART-CSET, LMS-04, HOPE 207, COMBINAIR3, IMODI, STARTRK-2 (RXDX-101-02), STOP MUCITES , MetZolimOS, ISI-JX, CLDK378A2407 ASCEND10, THEODORA, CABOGIST EORTC 1317 , RNASARC, CRAD001X2109, AVARTHEC, REVENRI, DCC-2618-03-001 INVICTUS, AcSé pembrolizumab, ANITA EORTC1506 , 20140114, XGEVA AMGEN 20150360, MICCHADO, TAPPAS 105SAR301 TRACON , PROFILER 02, EORTC-1506-STBSG-ANITA

Clinical trial other
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description :

Centre of treatment
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No
Description : Établissement dans lequel le patient est inclus dans l'essai clinique<br> Possible values :
CC Bordeaux CLCC/CHU, CC Lyon CLCC/CHU, CC IGR, CE Angers CLCC/CHU, CE Besançon CLCC/CHU, CE Caen CLCC/CHU, CE Clermond-Ferrand CLCC/CHU, CE Dijon CLCC/CHU, CE La Réunion, CE Lille CLCC/CHU, CE Limoges CHU, CE Marseille CHU Timone, CE Marseille CLCC, CE Montpellier CLCC/CHU, CE Nancy CLCC/CHU, CE Nantes CLCC, CE Nantes CHU, CE Nice CLCC/CHU, CE Paris Pitié Salpétrière, CE Paris Tenon , CE Paris Cochin, CE Paris Curie , CE Paris Saint Louis, CE Reims CLCC/CHU, CE Rennes/Brest CLCC/CHU, CE Rouen CLCC/CHU, CE Strasbourg CLCC/CHU, CE Toulouse CLCC/CHU, CE Tours CHU, Autre